SCHEMBL26601926

SCHEMBL26601926

Cc1cc(C(C)(C)C)c(Cl)cc1-c1cc(=O)c(-c2ccnc(C(N)=O)n2)c(C)[nH]1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMO O15229 2/20 0.35
▸ JAK2 O60674 14/20 0.35
▸ CDK2 P24941 3/20 0.32
▸ CDC7 O00311 2/20 0.32
▸ PLK4 O00444 2/20 0.32
▸ MAPK13 O15264 2/20 0.32
▸ DAPK3 O43293 2/20 0.32
▸ DYRK3 O43781 2/20 0.32
▸ ROCK2 O75116 2/20 0.32
▸ PRKD3 O94806 2/20 0.32
▸ MAP4K4 O95819 2/20 0.32
▸ PRKCG P05129 2/20 0.32
▸ CDK1 P06493 2/20 0.32
▸ PIM1 P11309 2/20 0.32
▸ PRKACA P17612 2/20 0.32
▸ MARK3 P27448 2/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ FRK P42685 2/20 0.32
▸ MAPK8 P45983 2/20 0.32
▸ MAPK9 P45984 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30624550 1.00 KMO (0.35) KMOJAK2CDK2CDC7PLK4
SCHEMBL26602678 0.86 KDM5B (0.33) JAK2MAP4K4PIM1MAPK8LRRK2
SCHEMBL26601855 0.84 SCN9A (0.36) PIM1IRAK4MAP3K14
SCHEMBL30624548 0.82 JAK2 (0.31) JAK2
SCHEMBL30624488 0.80 EIF4E (0.33) —
SCHEMBL26602270 0.80 JAK2 (0.31) JAK2
SCHEMBL26707612 0.79 ADORA2A (0.33) PIM1
SCHEMBL30624653 0.77 NPY5R (0.32) KDR
SCHEMBL26601846 0.77 NPY5R (0.32) KDR
SCHEMBL26601635 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023205465-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-26 — — WO disclosed
WO-2023205465-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-26 — — WO disclosed
Send feedback